Ad
related to: Oncology wikipedia
Search results
Centra brings back docs to hematology and oncology clinic
RockinghamNow.com, Eden and Reidssville· 4 days agoCentra Health announced both Dr. Cecilia MacCallum and Dr. Emaculate Tebit will be joining the...
Insider Sale: Chief Medical Officer of ALX Oncology Holdings Inc
Guru Focus· 5 days agoThe transaction was filed on May 15, 2024, as reported in the SEC Filing. ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused ...
New study suggests there's one way to detect signs of stomach cancer years before symptoms
UNILAD· 8 hours agoA new study has found promising results in regards to early detection of stomach cancer. Last year,...
AI chatbots show higher empathy, readability in responding to cancer questions, study finds
Medical Xpress· 1 day agoFor patient questions about cancer, artificial intelligence (AI) chatbots can generate quality,...
Predictive Oncology Inc (POAI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 5 days agoRelease Date: May 15, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Predictive Oncology Inc successfully ...
Anixa advances CAR-T trial for ovarian cancer with fifth patient By Investing.com
Investing.com· 60 minutes agoAnixa Biosciences, Inc. (NASDAQ: NASDAQ:ANIX), a clinical-stage biotechnology company, has begun...
Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN--Journal of the National Comprehensive...
CBS 47 Fresno· 5 days agoChief of the Genitourinary Division for Fox Chase Cancer Center, and Member of two NCCN Guidelines Panels to oversee high-impact oncology research journal. PLYMOUTH MEETING ...
Bipartisan bill to modernize radiation oncology re | Newswise
Newswise· 7 days agoThe Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act of 2024, sponsored by Sen. Thom Tillis (R-N.C.) (S. 4330) and by Reps...
AstraZeneca Aims for $80 Billion in Total Revenue by 2030
US News & World Report· 12 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal Soriot has turned ...
Tempus AI Files for Initial Public Offering
GenomeWeb News· 4 hours agoTempus AI on Monday filed documents with the US Securities and Exchange Commission for an initial public offering. According to its SEC document, the Chicago-based company intends to list its ...
